Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Poulter

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
American Journal of Preventive Medicine|January 22, 2020
Potassium Intake in India: Opportunity for Mitigating Risks of High-Sodium DietsShuchi Anand, Roopa Shivashankar, Dimple Kondal, et al.
Diabetologia|September 18, 2014
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesSophia Zoungas, Mark Woodward, Qiang Li, et al.
Diabetes Care|June 1, 2014
Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trialPaul Welsh, Mark Woodward, Graham S Hillis, et al.
European Journal of Preventive Cardiology|October 6, 2012
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeSimon Thom, Jane Field, Neil Poulter, et al.
Diabetes Care|October 29, 2017
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ONMin Jun, Toshiaki Ohkuma, Sophia Zoungas, et al.
American Heart Journal|June 2, 2019
Ablation versus Anti-Arrhythmic Therapy for Reducing All Hospital Episodes from Recurrent Atrial Fibrillation (AVATAR-AF): Design and rationaleIan Mann, Thiagarajah Sasikaran, Belinda Sandler, et al.
Cerebral Circulation - Cognition and Behavior|January 6, 2025
Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trialKatie Harris, Jessica Gong, Stephen MacMahon, et al.
Diabetologia|May 6, 2018
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trialPaul Welsh, Naomi Rankin, Qiang Li, et al.
BMJ Open|February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) studyDavid A Rorie, Amy Rogers, Isla S Mackenzie, et al.
Diabetes Care|February 27, 2009
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudyChristoph Stettler, Nicholas Witt, Robyn J Tapp, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
American Journal of Preventive Medicine|January 22, 2020
Potassium Intake in India: Opportunity for Mitigating Risks of High-Sodium DietsShuchi Anand, Roopa Shivashankar, Dimple Kondal, et al.
Diabetologia|September 18, 2014
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesSophia Zoungas, Mark Woodward, Qiang Li, et al.
Diabetes Care|June 1, 2014
Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trialPaul Welsh, Mark Woodward, Graham S Hillis, et al.
European Journal of Preventive Cardiology|October 6, 2012
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeSimon Thom, Jane Field, Neil Poulter, et al.
Diabetes Care|October 29, 2017
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ONMin Jun, Toshiaki Ohkuma, Sophia Zoungas, et al.
American Heart Journal|June 2, 2019
Ablation versus Anti-Arrhythmic Therapy for Reducing All Hospital Episodes from Recurrent Atrial Fibrillation (AVATAR-AF): Design and rationaleIan Mann, Thiagarajah Sasikaran, Belinda Sandler, et al.
Cerebral Circulation - Cognition and Behavior|January 6, 2025
Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trialKatie Harris, Jessica Gong, Stephen MacMahon, et al.
Diabetologia|May 6, 2018
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trialPaul Welsh, Naomi Rankin, Qiang Li, et al.
BMJ Open|February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) studyDavid A Rorie, Amy Rogers, Isla S Mackenzie, et al.
Diabetes Care|February 27, 2009
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudyChristoph Stettler, Nicholas Witt, Robyn J Tapp, et al.
Pageof 18